Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104
Authors
Keywords
Hypoxia, Leukemias, Cancer treatment, Oxygen, Immunohistochemistry techniques, Leukemia cells, Mouse models, Apoptosis
Journal
PLoS One
Volume 6, Issue 8, Pages e23108
Publisher
Public Library of Science (PLoS)
Online
2011-08-12
DOI
10.1371/journal.pone.0023108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug
- (2010) J. Hu et al. BLOOD
- Impact of interactions of cellular components of the bone marrow microenvironment on hematopoietic stem and progenitor cell function
- (2010) B. R. Chitteti et al. BLOOD
- Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches
- (2010) I. G. Winkler et al. BLOOD
- The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
- (2010) C. P. Guise et al. CANCER RESEARCH
- Noscapine, a Benzylisoquinoline Alkaloid, Sensitizes Leukemic Cells to Chemotherapeutic Agents and Cytokines by Modulating the NF- B Signaling Pathway
- (2010) B. Sung et al. CANCER RESEARCH
- Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF- B Pathway and Generation of Reactive Oxygen Species
- (2010) Y. Jin et al. CANCER RESEARCH
- The Distinct Metabolic Profile of Hematopoietic Stem Cells Reflects Their Location in a Hypoxic Niche
- (2010) Tugba Simsek et al. Cell Stem Cell
- Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells
- (2010) Keiyo Takubo et al. Cell Stem Cell
- NF-κB activation mediates resistance to IFNβ in MLL-rearranged acute lymphoblastic leukemia
- (2010) L Tracey et al. LEUKEMIA
- Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells
- (2010) S Colla et al. LEUKEMIA
- HIF-1 and HIF-2 transcription factors — Similar but not identical
- (2010) Agnieszka Loboda et al. MOLECULES AND CELLS
- The Role of NF-κB in Hypoxia-Induced Gene Expression
- (2009) Cormac T. Taylor et al. Annals of the New York Academy of Sciences
- The leukemic stem cell niche: current concepts and therapeutic opportunities
- (2009) S. W. Lane et al. BLOOD
- A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors
- (2009) Michael B. Jameson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DNA Cross-Links in Human Tumor Cells Exposed to the Prodrug PR-104A: Relationships to Hypoxia, Bioreductive Metabolism, and Cytotoxicity
- (2009) R. S. Singleton et al. CANCER RESEARCH
- Cancer stem cells and their niche
- (2009) Hiroko Iwasaki et al. CANCER SCIENCE
- Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia
- (2009) Shinae Kizaka-Kondoh et al. CANCER SCIENCE
- The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis
- (2009) Jane Birtwistle et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- Human cancers converge at the HIF-2α oncogenic axis
- (2009) Aleksandra Franovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIF-2 maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells
- (2009) A. Pietras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure
- (2008) M. Fiegl et al. BLOOD
- Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
- (2008) Z. Zeng et al. BLOOD
- Biology of HIF-1α
- (2008) A Weidemann et al. CELL DEATH AND DIFFERENTIATION
- A RNA antagonist of hypoxia-inducible factor-1 , EZN-2968, inhibits tumor cell growth
- (2008) L. M. Greenberger et al. MOLECULAR CANCER THERAPEUTICS
- Detection of functional haematopoietic stem cell niche using real-time imaging
- (2008) Yucai Xie et al. NATURE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started